Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole +/- Tegafur-uracil in Postmenopausal Breast Cancer
NCT01262274Phase 2Terminated
- Sponsor
- Translational Research Center for Medical Innovation
- Start
- Dec 2010
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur + uracil in breast cancer, sponsored by Translational Research Center for Medical Innovation. Started Dec 2010; status: terminated.
02
Drugs
tegafur + uracil
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01262274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01262274.